A Phase IIa, Open Label Study to Determine the Early Bactericidal,Extended Early Bactericidal Activity and Pharmacokinetic Study of LL 3858 of Lupin Limited for the Treatment of Newly Diagnosed Sputum Smear-Positive Pulmonary Tuberculosis.
Phase of Trial: Phase II
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Sudoterb (Primary)
- Indications Pulmonary tuberculosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Lupin
- 11 Dec 2013 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 30 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
- 09 Feb 2010 New trial record